Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2008) | Total Docs. (3years) | Total Refs. (2008) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2008) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Pharmacological Reviews | journal | 10.461 Q1 | 254 | 18 | 83 | 7023 | 1906 | 79 | 21.77 | 390.17 |  |
| 2 | Critical Reviews in Therapeutic Drug Carrier Systems | journal | 1.195 Q1 | 82 | 13 | 37 | 2583 | 142 | 37 | 3.65 | 198.69 | |
| 3 | Journal of Toxicology and Environmental Health - Part B: Critical Reviews | journal | 1.204 Q1 | 99 | 28 | 53 | 5091 | 239 | 50 | 3.78 | 181.82 |  |
| 4 | Pharmacology and Therapeutics | journal | 4.252 Q1 | 233 | 94 | 330 | 16214 | 3384 | 327 | 10.57 | 172.49 | |
| 5 | Medicinal Research Reviews | journal | 2.488 Q1 | 150 | 31 | 83 | 5055 | 673 | 83 | 8.81 | 163.06 | |
| 6 | Natural Product Reports | journal | 2.918 Q1 | 211 | 58 | 167 | 8919 | 1101 | 162 | 6.38 | 153.78 | |
| 7 | Advances in Pharmacology | journal | 1.129 Q1 | 86 | 17 | 76 | 2561 | 187 | 70 | 2.88 | 150.65 | |
| 8 | Reviews of Physiology Biochemistry and Pharmacology | journal | 3.780 Q1 | 70 | 5 | 25 | 733 | 150 | 25 | 6.47 | 146.60 |  |
| 9 | Food and Drug Law Journal | journal | 0.275 Q3 | 23 | 43 | 105 | 6119 | 45 | 104 | 0.43 | 142.30 | |
| 10 | Drug Resistance Updates | journal | 2.826 Q1 | 132 | 16 | 65 | 2260 | 527 | 63 | 9.17 | 141.25 | |
| 11 | Progress in Medicinal Chemistry | journal | 1.350 Q1 | 38 | 8 | 21 | 1130 | 66 | 18 | 2.08 | 141.25 |  |
| 12 | Annual Review of Pharmacology and Toxicology | journal | 11.171 Q1 | 224 | 23 | 70 | 3175 | 1700 | 70 | 23.83 | 138.04 | |
| 13 | Expert Opinion on Emerging Drugs | journal | 0.986 Q2 | 54 | 43 | 144 | 5144 | 459 | 144 | 3.44 | 119.63 | |
| 14 | Critical Reviews in Toxicology | journal | 2.095 Q1 | 129 | 44 | 97 | 5208 | 694 | 91 | 7.31 | 118.36 | |
| 15 | Advanced Drug Delivery Reviews | journal | 3.144 Q1 | 366 | 140 | 369 | 14876 | 3511 | 310 | 8.31 | 106.26 | |
| 16 | Profiles of Drug Substances, Excipients and Related Methodology | journal | 0.139 Q3 | 29 | 3 | 29 | 313 | 5 | 24 | 0.00 | 104.33 | |
| 17 | Handbook of Experimental Pharmacology | journal | 1.701 Q1 | 110 | 122 | 420 | 12459 | 1161 | 407 | 2.75 | 102.12 | |
| 18 | Cellular and Molecular Life Sciences | journal | 3.544 Q1 | 261 | 310 | 804 | 31629 | 4941 | 799 | 5.91 | 102.03 |  |
| 19 | Expert Opinion on Therapeutic Targets | journal | 1.533 Q1 | 106 | 127 | 307 | 12944 | 1104 | 285 | 3.83 | 101.92 | |
| 20 | Expert Opinion on Drug Delivery | journal | 0.942 Q1 | 133 | 98 | 201 | 9837 | 652 | 190 | 3.37 | 100.38 | |
| 21 | Current Drug Metabolism | journal | 1.182 Q1 | 122 | 114 | 183 | 11387 | 1012 | 177 | 5.06 | 99.89 | |
| 22 | Inflammation and Allergy - Drug Targets | journal | 1.085 Q2 | 55 | 35 | 62 | 3477 | 157 | 57 | 2.53 | 99.34 | |
| 23 | Drug Metabolism Reviews | journal | 1.561 Q1 | 108 | 24 | 110 | 2299 | 600 | 106 | 5.22 | 95.79 | |
| 24 | Recent Patents on Cardiovascular Drug Discovery | journal | 0.237 Q4 | 30 | 24 | 54 | 2294 | 47 | 54 | 0.87 | 95.58 | |
| 25 | Perspectives in Medicinal Chemistry | journal | 17 | 7 | 0 | 666 | 0 | 0 | 0.00 | 95.14 |  | |
| 26 | Expert Opinion on Drug Discovery | journal | 0.319 Q3 | 84 | 106 | 197 | 9775 | 201 | 194 | 1.02 | 92.22 | |
| 27 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.952 Q2 | 100 | 123 | 187 | 10962 | 769 | 182 | 3.74 | 89.12 | |
| 28 | Expert Opinion on Therapeutic Patents | journal | 0.505 Q3 | 88 | 102 | 350 | 8712 | 432 | 339 | 1.18 | 85.41 | |
| 29 | PPAR Research | journal | 0.747 Q2 | 59 | 117 | 52 | 9910 | 126 | 47 | 2.42 | 84.70 | |
| 30 | Expert Opinion on Biological Therapy | journal | 1.198 Q1 | 102 | 171 | 423 | 14412 | 1417 | 421 | 3.76 | 84.28 | |
| 31 | CNS Neuroscience and Therapeutics | journal | 91 | 31 | 0 | 2582 | 0 | 0 | 0.00 | 83.29 | | |
| 32 | BioDrugs | journal | 1.121 Q1 | 79 | 38 | 123 | 3093 | 420 | 117 | 2.97 | 81.39 | |
| 33 | Neurotherapeutics | journal | 2.162 Q1 | 136 | 65 | 191 | 5266 | 1146 | 175 | 4.68 | 81.02 | |
| 34 | Neurotoxicity Research | journal | 1.136 Q1 | 84 | 54 | 153 | 4240 | 504 | 152 | 3.29 | 78.52 | |
| 35 | Current Pharmaceutical Biotechnology | journal | 1.044 Q1 | 97 | 62 | 152 | 4851 | 410 | 134 | 2.65 | 78.24 | |
| 36 | Molecular Diagnosis and Therapy | journal | 0.704 Q2 | 68 | 38 | 146 | 2967 | 342 | 141 | 2.46 | 78.08 | |
| 37 | Expert Review of Vaccines | journal | 1.038 Q1 | 105 | 137 | 255 | 10660 | 762 | 232 | 2.97 | 77.81 | |
| 38 | Expert Opinion on Pharmacotherapy | journal | 0.595 Q2 | 93 | 294 | 742 | 21461 | 1699 | 724 | 2.45 | 73.00 | |
| 39 | Toxin Reviews | journal | 0.174 Q4 | 54 | 19 | 69 | 1383 | 32 | 65 | 0.56 | 72.79 | |
| 40 | Marine Drugs | journal | 0.438 Q3 | 159 | 34 | 47 | 2459 | 56 | 46 | 1.17 | 72.32 | |
| 41 | Expert Opinion on Investigational Drugs | journal | 1.249 Q1 | 117 | 173 | 445 | 12481 | 1750 | 418 | 3.98 | 72.14 | |
| 42 | Expert Review of Clinical Pharmacology | journal | 60 | 71 | 0 | 5038 | 0 | 0 | 0.00 | 70.96 | | |
| 43 | Current Opinion in Investigational Drugs | journal | 1.135 Q1 | 83 | 126 | 393 | 8936 | 1223 | 361 | 3.56 | 70.92 | |
| 44 | Current Opinion in Molecular Therapeutics | journal | 1.069 Q1 | 67 | 71 | 223 | 4806 | 612 | 201 | 3.10 | 67.69 | |
| 45 | Clinical Pharmacokinetics | journal | 1.480 Q1 | 184 | 62 | 236 | 4132 | 1372 | 224 | 5.00 | 66.65 | |
| 46 | Core Evidence (discontinued) | journal | 0.120 Q4 | 29 | 18 | 30 | 1192 | 2 | 29 | 0.00 | 66.22 | |
| 47 | Drug Discovery Today: Disease Mechanisms | journal | 0.208 Q4 | 28 | 38 | 197 | 2432 | 84 | 175 | 0.41 | 64.00 | |
| 48 | Neuropsychopharmacology | journal | 3.385 Q1 | 249 | 303 | 770 | 19353 | 5141 | 742 | 6.37 | 63.87 | |
| 49 | Addiction Biology | journal | 1.720 Q1 | 93 | 47 | 115 | 2938 | 451 | 107 | 4.65 | 62.51 | |
| 50 | Biomarker Insights | journal | 40 | 46 | 0 | 2862 | 0 | 0 | 0.00 | 62.22 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data